• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FDG-PET 代谢亢进与低淀粉样蛋白-PET 水平下轻度认知障碍的更高 tau-PET 相关。

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels.

机构信息

Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Feodor-Lynen-Straße 17, 81377, Munich, Germany.

German Center for Neurodegenerative Diseases, Munich, Germany.

出版信息

Alzheimers Res Ther. 2020 Oct 19;12(1):133. doi: 10.1186/s13195-020-00702-6.

DOI:10.1186/s13195-020-00702-6
PMID:33076977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7574434/
Abstract

BACKGROUND

FDG-PET hypermetabolism can be observed in mild cognitive impairment (MCI), but the link to primary pathologies of Alzheimer's diseases (AD) including amyloid and tau is unclear.

METHODS

Using voxel-based regression, we assessed local interactions between amyloid- and tau-PET on spatially matched FDG-PET in 72 MCI patients. Control groups included cerebrospinal fluid biomarker characterized cognitively normal (CN, n = 70) and AD dementia subjects (n = 95).

RESULTS

In MCI, significant amyloid-PET by tau-PET interactions were found in frontal, lateral temporal, and posterior parietal regions, where higher local tau-PET was associated with higher spatially corresponding FDG-PET at low levels of local amyloid-PET. FDG-PET in brain regions with a significant local amyloid- by tau-PET interaction was higher compared to that in CN and AD dementia and associated with lower episodic memory.

CONCLUSION

Higher tau-PET in the presence of low amyloid-PET is associated with abnormally increased glucose metabolism that is accompanied by episodic memory impairment.

摘要

背景

轻度认知障碍(MCI)中可观察到 FDG-PET 代谢亢进,但与阿尔茨海默病(AD)的主要病理包括淀粉样蛋白和 tau 的联系尚不清楚。

方法

使用基于体素的回归,我们评估了 72 名 MCI 患者空间匹配的 FDG-PET 中淀粉样蛋白和 tau-PET 之间的局部相互作用。对照组包括脑脊液生物标志物特征认知正常(CN,n=70)和 AD 痴呆患者(n=95)。

结果

在 MCI 中,在前额、外侧颞叶和后顶叶区域发现了显著的淀粉样蛋白与 tau-PET 相互作用,其中局部 tau-PET 越高,与低水平局部淀粉样蛋白相应的空间匹配 FDG-PET 越高。与 CN 和 AD 痴呆相比,在具有显著局部淀粉样蛋白与 tau-PET 相互作用的脑区,FDG-PET 更高,且与情景记忆受损相关。

结论

在低淀粉样蛋白存在的情况下,tau-PET 越高与异常增加的葡萄糖代谢相关,伴有情景记忆障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/75cb5c39c0d6/13195_2020_702_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/67624fca1347/13195_2020_702_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/6b659a9f832f/13195_2020_702_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/6363c6ca8025/13195_2020_702_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/75cb5c39c0d6/13195_2020_702_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/67624fca1347/13195_2020_702_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/6b659a9f832f/13195_2020_702_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/6363c6ca8025/13195_2020_702_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d84d/7574434/75cb5c39c0d6/13195_2020_702_Fig5_HTML.jpg

相似文献

1
FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels.FDG-PET 代谢亢进与低淀粉样蛋白-PET 水平下轻度认知障碍的更高 tau-PET 相关。
Alzheimers Res Ther. 2020 Oct 19;12(1):133. doi: 10.1186/s13195-020-00702-6.
2
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey.阿尔茨海默病生物标志物在轻度认知障碍患者中的临床应用:欧洲阿尔茨海默病联合会调查。
J Alzheimers Dis. 2022;89(2):535-551. doi: 10.3233/JAD-220333.
3
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
4
What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?ADNI研究对象中最常受损的神经退行性变标志物有哪些?
J Alzheimers Dis. 2016;51(3):793-800. doi: 10.3233/JAD-150829.
5
Clinical Relevance of [F]Florbetaben and [F]FDG PET/CT Imaging on the Management of Patients with Dementia.[F]氟替卡滨和[F]FDG PET/CT 成像在痴呆患者管理中的临床相关性。
Molecules. 2021 Feb 26;26(5):1282. doi: 10.3390/molecules26051282.
6
A biomarker study in long-lasting amnestic mild cognitive impairment.一项针对持续性遗忘型轻度认知障碍的生物标志物研究。
Alzheimers Res Ther. 2018 Apr 25;10(1):42. doi: 10.1186/s13195-018-0369-8.
7
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.淀粉样蛋白级联和 tau 病理学脑脊液标志物在轻度认知障碍阿尔茨海默病大脑代谢特征方面。
J Alzheimers Dis. 2013;36(2):401-8. doi: 10.3233/JAD-122329.
8
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.18F-FDG 在阿尔茨海默病和轻度认知障碍评估中比 18F-氟比他滨更能准确反映认知表现:一项全球定量分析。
J Alzheimers Dis. 2019;70(4):1197-1207. doi: 10.3233/JAD-190220.
9
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.18F-FDG-PET与脑脊液生物标志物在疑似阿尔茨海默病且首次生物标志物结果不确定的轻度认知障碍患者中的相互增量价值
J Alzheimers Dis. 2019;72(4):1193-1207. doi: 10.3233/JAD-190539.
10
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.18F-FDG和淀粉样蛋白PET的视觉分析与全自动分析对轻度认知障碍患者阿尔茨海默病所致痴呆的预测作用
J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.

引用本文的文献

1
Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease.线粒体DNA影响衰老和阿尔茨海默病中的tau蛋白磷酸化。
Alzheimers Dement. 2025 Jul;21(7):e70390. doi: 10.1002/alz.70390.
2
Metabolism as a biomarker for treatment success in anti-amyloid therapy: A case report.代谢作为抗淀粉样蛋白治疗成功的生物标志物:一例报告。
Neuroimage Rep. 2024 Apr 27;4(2):100203. doi: 10.1016/j.ynirp.2024.100203. eCollection 2024 Jun.
3
Behavioral variant frontotemporal dementia (bvFTD): PET biomarker characterization of metabolism (18F-FDG), amyloid (11C-PIB) and tau (18F-AV1451) and its clinical correlate - analysis of a cohort from Argentina.

本文引用的文献

1
Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity.在阿尔茨海默病连续体中,无淀粉样蛋白情况下的tau蛋白是怎样的?一项PET阳性不一致的研究。
Brain Commun. 2020;2(1):fcz046. doi: 10.1093/braincomms/fcz046. Epub 2019 Dec 20.
2
Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo.在体内阿尔茨海默病模型中,tau 损害神经回路,主导淀粉样β的作用。
Nat Neurosci. 2019 Jan;22(1):57-64. doi: 10.1038/s41593-018-0289-8. Epub 2018 Dec 17.
3
Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.
行为变异型额颞叶痴呆(bvFTD):代谢(18F-FDG)、淀粉样蛋白(11C-PIB)和tau(18F-AV1451)的PET生物标志物特征及其临床相关性——来自阿根廷的队列分析
Alzheimers Dement. 2025 Apr;21(4):e70187. doi: 10.1002/alz.70187.
4
Characteristics of cerebral glucose metabolism in patients with cognitive impairment in multiple system atrophy.多系统萎缩认知障碍患者的脑葡萄糖代谢特征
Front Aging Neurosci. 2025 Mar 5;17:1520515. doi: 10.3389/fnagi.2025.1520515. eCollection 2025.
5
Tau-related reduction of glucose metabolism in mild cognitive impairment occurs independently of APOE ε4 genotype and is influenced by Aβ.轻度认知障碍中与tau蛋白相关的葡萄糖代谢降低独立于APOE ε4基因型发生,并受Aβ影响。
Alzheimers Dement. 2025 Feb;21(2):e14625. doi: 10.1002/alz.14625.
6
Early metabolic changes in the brain of Alzheimer's disease rats are driven by GLAST+ cells.阿尔茨海默病大鼠大脑中的早期代谢变化由GLAST+细胞驱动。
J Cereb Blood Flow Metab. 2025 Feb 7:271678X251318923. doi: 10.1177/0271678X251318923.
7
Cerebral hyperactivation across the Alzheimer's disease pathological cascade.阿尔茨海默病病理级联反应中的大脑过度激活。
Brain Commun. 2024 Oct 25;6(6):fcae376. doi: 10.1093/braincomms/fcae376. eCollection 2024.
8
Screening of [F]Florbetazine for Aβ Plaques and a Head-to-Head Comparison Study with [C]Pittsburgh Compound-B ([C]PiB) in Human Subjects.用[F]氟贝他嗪筛查β淀粉样蛋白斑块以及在人体受试者中与[C]匹兹堡化合物-B([C]PiB)进行的直接比较研究。
ACS Pharmacol Transl Sci. 2024 Jun 25;7(7):2054-2062. doi: 10.1021/acsptsci.4c00149. eCollection 2024 Jul 12.
9
Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology.在不依赖淀粉样蛋白和 tau 病理的情况下,描述晚发性阿尔茨海默病小鼠模型中的分子和突触特征。
Alzheimers Dement. 2024 Jun;20(6):4126-4146. doi: 10.1002/alz.13828. Epub 2024 May 12.
10
Characterization of tau propagation pattern and cascading hypometabolism from functional connectivity in Alzheimer's disease.阿尔茨海默病中 tau 传播模式和级联低代谢的功能连接特征。
Hum Brain Mapp. 2024 May;45(7):e26689. doi: 10.1002/hbm.26689.
临床正常老年人的 Tau 积累与海马过度活跃有关。
J Neurosci. 2019 Jan 16;39(3):548-556. doi: 10.1523/JNEUROSCI.1397-18.2018. Epub 2018 Nov 27.
4
Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease.原发性年龄相关性 tau 病(PART)和阿尔茨海默病的神经病理学、遗传学和纵向认知特征。
Alzheimers Dement. 2019 Jan;15(1):8-16. doi: 10.1016/j.jalz.2018.07.215. Epub 2018 Dec 11.
5
Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?早期对神经元损伤的代偿反应:阿尔茨海默病治疗的新机会窗口?
CNS Neurosci Ther. 2019 Jan;25(1):5-13. doi: 10.1111/cns.13050. Epub 2018 Aug 12.
6
Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults.tau 与葡萄糖代谢之间的关系反映了认知正常的老年人群中的阿尔茨海默病病理。
Cereb Cortex. 2019 May 1;29(5):1997-2009. doi: 10.1093/cercor/bhy078.
7
Neuronal levels and sequence of tau modulate the power of brain rhythms.神经元水平和 tau 序列调节脑节律的功率。
Neurobiol Dis. 2018 Sep;117:181-188. doi: 10.1016/j.nbd.2018.05.020. Epub 2018 May 31.
8
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.典型和非典型阿尔茨海默病中 tau、淀粉样蛋白、代谢和萎缩的影像学相关性。
Alzheimers Dement. 2018 Aug;14(8):1005-1014. doi: 10.1016/j.jalz.2018.02.020. Epub 2018 Mar 30.
9
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.阿尔茨海默病的脑脊液生物标志物与淀粉样蛋白-β PET 一致,并可预测临床进展:在 BioFINDER 和 ADNI 队列中使用全自动免疫分析的研究。
Alzheimers Dement. 2018 Nov;14(11):1470-1481. doi: 10.1016/j.jalz.2018.01.010. Epub 2018 Mar 1.
10
Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation.认知障碍患者海马结构中的代谢亢进表明有害的适应不良。
Neurobiol Aging. 2018 May;65:41-50. doi: 10.1016/j.neurobiolaging.2018.01.002. Epub 2018 Jan 31.